Neck injection may stop Post-Mastectomy depression
NCT ID NCT06263907
First seen Feb 21, 2026 · Last updated Jun 19, 2026 · Updated 14 times
Summary
This study tests whether a stellate ganglion block (a nerve injection in the neck) given before mastectomy can prevent depression and chronic pain afterward. Researchers will compare 140 women who receive the block to those who do not, tracking depression scores and pain levels for months after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maha
RECRUITINGAl Mansurah, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
stellate ganglion block (a nerve block injection in the neck)
What this could lead to
If it works, this could offer a simple, one-time procedure to prevent depression and chronic pain after mastectomy.
What could go wrong
This is a small, early-stage trial with no phase designation, so results are uncertain. The nerve block carries risks like bleeding, infection, or temporary Horner syndrome.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.